Inhibitor Therapeutics, Inc. Dividends, Preferred Stock
Inhibitor Therapeutics, Inc. (INTI) reported Dividends, Preferred Stock of $189.04 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Shareholders' Equity › Dividends, Preferred Stock
us-gaap:DividendsPreferredStock · last filed 2024-03-29
- Inhibitor Therapeutics, Inc. dividends, preferred stock for the quarter ending 2022-09-30 was $50.41K, a 0.00% decline year-over-year.
- Inhibitor Therapeutics, Inc. dividends, preferred stock for the quarter ending 2022-06-30 was $49.86K, a 0.00% change year-over-year.
- Inhibitor Therapeutics, Inc. dividends, preferred stock for the quarter ending 2022-03-31 was $49.31K, a 0.00% change year-over-year.
- Inhibitor Therapeutics, Inc. dividends, preferred stock for the quarter ending 2021-09-30 was $50.41K, a 0.00% increase year-over-year.
- Inhibitor Therapeutics, Inc. dividends, preferred stock for fiscal 2022 was $189.04K, a 5.48% decline from fiscal 2021.
- Inhibitor Therapeutics, Inc. dividends, preferred stock for fiscal 2021 was $200.00K, a 0.27% decline from fiscal 2020.
- Inhibitor Therapeutics, Inc. dividends, preferred stock for fiscal 2020 was $200.55K, a 0.27% increase from fiscal 2019.
- Inhibitor Therapeutics, Inc. dividends, preferred stock for fiscal 2019 was $200.00K, a 27.80% increase from fiscal 2018.
| Period end | Dividends, Preferred Stock 3 month | Dividends, Preferred Stock 3 month as first filed | Dividends, Preferred Stock 6 month | Dividends, Preferred Stock 9 month | Dividends, Preferred Stock 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $189.04K 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $50.41K 10-Q · filed 2023-11-13 | $100.27K derived: sum of 2 quarters · filed 2023-11-13 | $149.59K derived: sum of 3 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $49.86K 10-Q · filed 2023-11-13 | $49.86K 10-Q · filed 2022-08-12 | $99.18K derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2022-03-31 | $49.31K 10-Q · filed 2023-11-13 | ||||
| 2021-12-31 | $200.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $50.41K 10-Q · filed 2022-11-14 | $100.28K derived: sum of 2 quarters · filed 2022-11-14 | $149.59K derived: sum of 3 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $49.86K 10-Q · filed 2022-11-14 | $99.18K derived: sum of 2 quarters · filed 2022-11-14 | |||
| 2021-03-31 | $49.31K 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | $200.55K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $50.41K 10-Q · filed 2021-11-12 | $100.27K derived: sum of 2 quarters · filed 2021-11-12 | $150.14K derived: sum of 3 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $49.86K 10-Q · filed 2021-11-12 | $99.73K derived: sum of 2 quarters · filed 2021-11-12 | |||
| 2020-03-31 | $49.86K 10-Q · filed 2021-11-12 | ||||
| 2019-12-31 | $200.00K 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | $50.41K 10-Q · filed 2020-11-16 | $100.27K derived: sum of 2 quarters · filed 2020-11-16 | $149.59K derived: sum of 3 quarters · filed 2020-11-16 | $200.00K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | $49.86K 10-Q · filed 2020-11-16 | $99.18K derived: sum of 2 quarters · filed 2020-11-16 | $149.59K derived: sum of 3 quarters · filed 2020-11-16 | $199.12K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-03-31 | $49.31K 10-Q · filed 2020-11-16 | $99.73K derived: sum of 2 quarters · filed 2020-11-16 | $149.26K derived: sum of 3 quarters · filed 2020-11-16 | $179.18K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2018-12-31 | $50.41K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $99.94K derived: sum of 2 quarters · filed 2020-03-30 | $129.86K derived: sum of 3 quarters · filed 2020-03-30 | $156.49K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $49.53K 10-Q · filed 2019-11-07 | $79.45K derived: sum of 2 quarters · filed 2019-11-07 | $106.08K 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | $29.92K 10-Q · filed 2019-11-07 | $56.55K 10-Q · filed 2018-07-23 | |||
| 2018-03-31 | $26.63K 10-Q · filed 2019-11-07 |